Evidence map›Paper›PMID 36499937›Full record

ArticleMaterials (Basel, Switzerland)2022

Effect of Sn Addition on Microstructure, Aging Properties and Softening Resistance of Cu-Cr Alloy.

Gaolei Xu, Yunqing Zhu, Lijun Peng, Haofeng Xie, Zengde Li, Shuhui Huang, Zhen Yang, Wenjing Zhang, Xujun Mi

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gaolei XuState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Yunqing ZhuState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Lijun PengState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Haofeng XieState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Zengde LiState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Shuhui HuangState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Zhen YangState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Wenjing ZhangState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.
Xujun MiState Key Laboratory of Nonferrous Metals and Processes, GRIMAT Group Co., Ltd., Beijing 100088, China.

Funding

National Key R&D Program of China No.2021YFB3803100National Natural Science Foundation of China No. 51601017technological innovation 2025 & Major special project of NingBo No. 2020Z039
6 · The paper itself

Abstract

The relationship between microstructure evolution and properties of a Cu-Cr-Sn alloy during aging and high-temperature softening was investigated in detail in the present work. The results show that the addition of Sn refines obviously the size of the Cr phase and enhances the thermal stability of the alloy, which improves the peak-aged hardness of the Cu-Cr-Sn alloy reaching 139 HV after aging at 450 °C for 240 min. In addition, the recrystallization behavior of the Cu-Cr alloy with the 0.12 wt.% of Sn at high temperature is also significantly inhibited. Lots of precipitated Cr phases and a high density of dislocations are found in the Cu-Cr-Sn alloy annealed at high temperature, resulting in the softening temperature of the Cu-Cr-Sn alloy reaching 565 °C, which is higher than (about 50 °C) that of the Cu-Cr alloy.

Indexed as

aging treatmentCu-Cr-Sn alloymicrostructure evolutionsoftening resistance

Identifiers

PMID36499937
PMCPMC9735822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.